Different laser prostatectomy for benign prostatic hyperplasia: What is the role of outcome-effectiveness analysis in clinical practice?  by Tsui, Ke-Hung
ble at ScienceDirect
Urological Science 27 (2016) 1e2Contents lists availaUrological Science
journal homepage: www.urol-sci .comEditorialDifferent laser prostatectomy for benign prostatic hyperplasia: What is
the role of outcome-effectiveness analysis in clinical practice?Laser prostatectomy is the most rigorously studied current op-
tion for the surgical management of benign prostatic hyperplasia
(BPH). In randomized controlled trials, laser prostatectomy has
been compared to transurethral resection of the prostate (TURP)
and was associated with superior outcomes.1e4 Furthermore, laser
prostatectomy may be safely used for prostates that are too large
for TURP. Laser prostatectomy outcomes are independent of the
size of the treated gland.5
Several initial laser techniques have been introduced to make
prostatectomy procedures safer and more effective. Such tech-
niques include the use of high-powered 120 W (GreenLightTM
HPS; American Medical Systems, Minnetonka, MN, USA), thulium
(Tm), diode, holmium, and vela lasers. Depending on the wave-
length, power, and type of laser emission, the techniques consist
of coagulation (e.g., photoselective vaporization of the prostate
[PVP]), vaporization (i.e., PVP and diode), resection, and enucle-
ation (Tm). These methods have been proven as safe for patients
with a high risk of bleeding (e.g., anticoagulant users, patients
with a bleeding tendency, or patients with an American Society
of Anesthesiology score of 3).5,6
TheMedicine Journal features an important article by Hsu et al.5
In one study by Lee et al,6 the authors evaluated the outcomes after
more than 1 year in approximately 741 men treated by different
laser prostatectomy procedures. Their ﬁndings conﬁrm our experi-
ence: laser prostatectomy is associated with improved ﬂow rates
and symptom scores typical of what would be expected from a
debulking BPH procedure such as TURP or an open simple prosta-
tectomy. These outcomes were produced with remarkably little
morbidity, which is a common theme with laser prostatectomy.6
Tsui et al also conﬁrm that laser prostatectomy is associated
with a dramatic and sustained decrease in the prostate speciﬁc an-
tigen level, which was comparable to its level after TURP. This
ﬁnding is entirely consistent with the nature of the laser prostatec-
tomy procedure (e.g., Tm, PVP, and diode lasers), which involves the
removal of the entire transition zone and represents anatomically
the same degree of tissue removal as TURP surgery. Taken together,
PVP laser is also a high cost-effective technology.
This study uses an innovative model to compare procedural
treatment options for BPH. In comparison to TURP, laserhttp://dx.doi.org/10.1016/j.urols.2016.02.001
1879-5226/Copyright © 2016, Taiwan Urological Association. Published by Elsevier Ta
creativecommons.org/licenses/by-nc-nd/4.0/).prostatectomy is clinically effective, but it is a high-cost treatment
for symptomatic BPH because of the cost of the laser equipment.
Laser prostatectomy is a more sophisticated and acceptable modal-
ity for the treatment of BPH because of the efﬁciency, short learning
curve, and lowmorbidity proﬁle of using laser prostatectomy. How-
ever, because the laser is a new technology, the expense, safety pre-
cautions, long-term effectiveness, and general acceptance are all
important limiting factors.5
Laser prostatectomy is increasingly considered a valid clinical
alternative to TURP. This study compared the efﬁcacy of three laser
techniques used to treat lower urinary tract symptoms due to BPH.
Photoselective vaporization of the prostate, a coagulation-based
technique, has durable efﬁcacy for prostates weighing 60 g. The
Tm laser (i.e., an enucleation laser technique) has previously been
criticized for having a steep learning curve because this laser re-
quires a certain volume of enucleated tissue. However, our evi-
dence supports the contention that Tm offers favorable and
durable outcomes for prostates of any size and low morbidity rates
(both early and late). Prostatectomy using the GreenLight HPS laser
(American Medical Systems) is more widely accepted and offers
favorable outcomes for prostates weighing 60 g. Diode laser prosta-
tectomy, a coagulation-based technique, is preferred for prostates
weighing 60 g and for patients with thrombocytopenia or who
have a bleeding tendency.
In our study, these techniques were equally safe and effective in
treating BPH without any severe drawbacks, as long as patients
were selected according to risk factors. However, to conﬁrm our re-
sults, future research should use higher quality data to further eval-
uate and compare different types of laser treatment.
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